Losartan
Idiopathic Pulmonary Fibrosis
Clinical trials
3
Developer
University of Kansas Medical Center
Overview
Losartan is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.
Losartan clinical trials
Explore related
Medical disclaimer. This page summarizes research about Losartan for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.